<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Journal of Turkish Family Physicianaugmentative alternative communication Archives - The Journal of Turkish Family Physician</title>
	<atom:link href="http://turkishfamilyphysician.com/etiket/augmentative-alternative-communication/feed/" rel="self" type="application/rss+xml" />
	<link>http://turkishfamilyphysician.com</link>
	<description>Online Dergi2</description>
	<lastBuildDate>Thu, 02 Apr 2026 08:13:36 +0000</lastBuildDate>
	<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
	
	<item>
		<title>Communication with the patiens of Amyotrophic Lateral Sclerosis and current technology</title>
		<link>http://turkishfamilyphysician.com/articles/review/communication-with-the-patiens-of-amyotrophic-lateral-sclerosis-and-current-technology/</link>
		<pubDate>Thu, 15 Jun 2017 06:17:41 +0000</pubDate>
					<dc:creator><![CDATA[Alper Kaya]]></dc:creator>
						<dc:creator><![CDATA[Fatih Özcan]]></dc:creator>
					
				<category><![CDATA[Review]]></category>
		<category><![CDATA[Amyotrophic Lateral Sclerosis]]></category>
		<category><![CDATA[assistive technology]]></category>
		<category><![CDATA[augmentative alternative communication]]></category>

		<guid isPermaLink="false">http://turkishfamilyphysician.com/?p=9515</guid>
		<description><![CDATA[<p>Giriş Amiyotrofik lateral skleroz (ALS) en sık görülen kazanılmış motor nöron hastalığıdır. Ülkemizde kesin rakamlar olmamakla birlikte dünya üzerinde prevalansı 3-8/100.000, yıllık insidansı ise 1-2/100.000 olarak bildirilmektedir. Ortalama başlangıç yaşı 55 yaştır. Aile öyküsünün olduğu formlarda bu yaş daha erkene kaymaktadır. Erkek / kadın oranı: 1,6/1’dir. Semptomların başlamasını takiben ortalama yaşam süresi 3-5 yıl olmakla [&#8230;]</p>
<p>The post <a rel="nofollow" href="http://turkishfamilyphysician.com/articles/review/communication-with-the-patiens-of-amyotrophic-lateral-sclerosis-and-current-technology/">Communication with the patiens of Amyotrophic Lateral Sclerosis and current technology</a> appeared first on <a rel="nofollow" href="http://turkishfamilyphysician.com">The Journal of Turkish Family Physician</a>.</p>
]]></description>
		
		</item>
	</channel>
</rss>
